Report
Oliver Metzger

Fresenius Medical Care : ESRD PPS bundle rate with the first positive surprise for a long time

>ESRD PPS bundle rate set at 2.7% for 2025 - The Center for Medicare & Medicaid Services (CMS) issued a proposed rule for the bundle rate under the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) for dialysis service from 1 January 2025, which corresponds to an increase of 2.7%. The rate is always the reflection of the changed cost position of the aggregated dialysis industry in the US as a whole and changes in the cost base are reflected basically wit...
Underlying
FRESENIUS MEDICAL CARE AG

RegistrarFresenius Medical Care is a kidney dialysis company, operating in both the field of dialysis services and the field of dialysis products for the treatment of end-stage renal disease (ESRD). Co.'s dialysis business is vertically integrated, providing dialysis treatment at dialysis clinics it owns or operates and supplying these clinics with a range of products. In addition, Co. sells dialysis products to other dialysis service providers. In the U.S.A., Co. also provides inpatient dialysis services and other services under contract to hospitals. Co. provides patient services, including renal pharmaceutical products and in the U.S.A., laboratory services.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oliver Metzger

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch